Self-complementary adeno-associated virus serotype 2 vector: Global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain

被引:130
|
作者
Fu, HY
Muenzer, J
Samulski, RJ
Breese, G
Sifford, J
Zeng, XH
McCarty, DM
机构
[1] Univ N Carolina, Gene Therapy Ctr, Sch Med, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA
[4] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA
[5] Univ N Carolina, Sch Pharm, Chapel Hill, NC 27599 USA
关键词
D O I
10.1016/j.ymthe.2003.08.021
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The blood-brain barrier is the main obstacle to efficient delivery of therapeutic reagents, including viral vectors, into the central nervous system (CNS) for treating global CNS diseases. In this study, the effects of mannitol infusions on global brain gene expression of a novel AAV vector were examined after intravenous (iv) or intracisternal injection. Initially, a self-complementary adeno-associated virus serotype 2 vector (scAAV) was compared to traditional single-stranded AAV2 vector for reporter gene expression in the brain of adult mice with or without pretreatment of an iv mannitol infusion. One to two months postinjection, analysis of vector-transduced green fluorescent protein (GFP) expression in the brain revealed that vector delivery to the CNS via iv injection required pretreatment with mannitol. This expression was observed only when scAAV vectors were used. Using these conditions, transgene expression was observed in various neurons and glial cells throughout the brain. The peripherally administered scAAV vectors also transduced the cells in multiple somatic tissues with efficient expression in liver (20-30% of hepatocytes), but was less efficient in other somatic tissues. Intracisternal injection of scAAV vector produced a broad and intense transgene expression in both neurons and glial cells in the CNS of injected mice ranging from the olfactory area to the brain stem and spinal cord. More than 50% of the Purkinje cells in the cerebellum expressed GFP. Intravenous infusion of mannitol before intracisternal injection of the scAAV vector enhanced the dispersion of the vector in the CNS. Further optimization of these steps combining peripheral and intracisternal scAAV gene delivery should facilitate the development of treatments for global CNS diseases, especially diseases involving both the somatic system and the CNS, such as lysosomal storage disorders.
引用
收藏
页码:911 / 917
页数:7
相关论文
共 50 条
  • [31] The Murine Dystrophic Muscle Environment Reduces Adeno-Associated Virus Vector-mediated Transgene Expression
    Dupont, Jean-Baptiste
    Leger, Adrien
    Penaud-Budloo, Magalie
    Bertil, Emilie
    Georger, Christophe
    Snyder, Richard
    Moullier, Philippe
    HUMAN GENE THERAPY, 2012, 23 (10) : A130 - A130
  • [32] The use of melittin to enhance transgene expression mediated by recombinant adeno-associated virus serotype 2 vectors both in vitro and in vivo
    Xie, Yi-lin
    Wang, Ji-yao
    He, Yun
    Yu, Xiao-min
    Zheng, Qing-yun
    Ling, Chen
    Feng, Xi-lin
    Zhu, Li-qing
    JOURNAL OF INTEGRATIVE MEDICINE-JIM, 2023, 21 (01): : 106 - 116
  • [33] The use of melittin to enhance transgene expression mediated by recombinant adeno-associated virus serotype 2 vectors both in vitro and in vivo
    Yi-lin Xie
    Ji-yao Wang
    Yun He
    Xiao-min Yu
    Qing-yun Zheng
    Chen Ling
    Xi-lin Feng
    Li-qing Zhu
    Journal of Integrative Medicine, 2023, 21 (01) : 106 - 116
  • [34] Lot-to-Lot Variation in Intrathecal Self-Complementary Adeno-Associated Virus Serotype 9 (scAAV9) Transduction
    Donsante, Anthony
    O'Connor, Deirdre
    Jarrold, Martin
    Lutomski, Corinne
    Boulis, Nicholas
    MOLECULAR THERAPY, 2018, 26 (05) : 188 - 188
  • [35] Variations in the patterns of transgene expression mediated by recombinant adeno-associated virus type 2 in the retina
    Shen, WY
    Lai, YKY
    Lai, CM
    Zaknich, T
    Constable, IJ
    Rakoczy, PE
    JOURNAL OF GENE MEDICINE, 2003, 5 (05): : S15 - S16
  • [36] A novel epigenetic modifier significantly improves recombinant adeno-associated virus vector mediated transgene expression in mice
    Rosales, C.
    McIntosh, J.
    Hanley, J.
    Nathwani, A.
    Morton, C.
    Davidoff, A.
    HUMAN GENE THERAPY, 2011, 22 (10) : A107 - A107
  • [37] Improving adeno-associated viral (AAV) vector-mediated transgene expression in retinal ganglion cells: comparison of five promoters
    Nieuwenhuis, Bart
    Laperrousaz, Elise
    Tribble, James R.
    Verhaagen, Joost
    Fawcett, James W.
    Martin, Keith R.
    Williams, Pete A.
    Osborne, Andrew
    GENE THERAPY, 2023, 30 (06) : 503 - 519
  • [38] Improving adeno-associated viral (AAV) vector-mediated transgene expression in retinal ganglion cells: comparison of five promoters
    Bart Nieuwenhuis
    Elise Laperrousaz
    James R. Tribble
    Joost Verhaagen
    James W. Fawcett
    Keith R. Martin
    Pete A. Williams
    Andrew Osborne
    Gene Therapy, 2023, 30 : 503 - 519
  • [39] Percutaneous Transendocardial Delivery of Self-complementary Adeno-associated Virus 6 Achieves Global Cardiac Gene Transfer in Canines
    Bish, Lawrence T.
    Sleeper, Meg M.
    Brainard, Benjamin
    Cole, Stephen
    Russell, Nicholas
    Withnall, Elanor
    Arndt, Jason
    Reynolds, Caryn
    Davison, Ellen
    Sanmiguel, Julio
    Wu, Di
    Gao, Guangping
    Wilson, James M.
    Sweeney, H. Lee
    MOLECULAR THERAPY, 2008, 16 (12) : 1953 - 1959
  • [40] A combined therapeutic approach for pyruvate dehydrogenase deficiency using self-complementary adeno-associated virus serotype-specific vectors and dichloroacetate
    Han, Zongchao
    Berendzen, Kristen
    Zhong, Li
    Surolia, Ira
    Chouthai, Nitin
    Zhao, Weihong
    Maina, Njeri
    Srivastava, Arun
    Stacpoole, Peter W.
    MOLECULAR GENETICS AND METABOLISM, 2008, 93 (04) : 381 - 387